United States · Biotechnology startup
United States · Mustang Bio
Mustang Bio is a clinical-stage biopharmaceutical company .
Funding reportedLast round: Post ipo equity
What company datasets say Mustang Bio raised
Funding, as reported
Reported in all$215Min dollars
Rounds8
Last roundPost ipo equity
Last round dateJun 2024
Investors listed4
SEC Form D$240M sold, 9 filings, last Jun 2024
Founders and team
From the SEC filings it signed: 2 on the team.
- Manuel B. LitchmanPresident and Chief Executive Officeri
- James B MurphyInterim Chief Financial Officeri
On the board, as filediAdam J. ChillLindsay A. RosenwaldMichael J. ZelefskyMichael S. WeissNeil A. Herskowitz
On 2 portfolio pages
Investors who name them
Each firm lists Mustang Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Mustang Bio in front of investors. Or tell us what we have wrong.